Evidence map›Paper›PMID 23201532›Full record

ReviewMicrobial pathogenesis2013

Dendritic cells and vaccine design for sexually-transmitted diseases.

Dorothee Duluc, Julien Gannevat, Hyemee Joo, Ling Ni, Katherine Upchurch, Muriel Boreham, Michael Carley, Jack Stecher, Gerard Zurawski, Sangkon Oh

Abstract readReview
In one paragraph

Review in Microbial pathogenesis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dorothee DulucBaylor Institute for Immunology Research, 3434 Live Oak, Dallas, TX 75204, USA.
Julien Gannevat
Hyemee Joo
Ling Ni
Katherine Upchurch
Muriel Boreham
Michael Carley
Jack Stecher
Gerard Zurawski
Sangkon Oh
Baylor University · USBaylor University Medical Center · US

Funding

Targeting Dendritic Cells for Enhanced Musocal ImmunityU19AI057234 · NIAID · BAYLOR RESEARCH INSTITUTE · PI BANCHEREAU, JACQUES F · 2003 to 2013
$49.2M
Immunotherapeutic HPV cancer vaccines that target Langerhans cellsRC2CA148460 · NCI · BAYLOR RESEARCH INSTITUTE · PI ZURAWSKI, GERARD · 2009 to 2010
$981k
Targeting Dendritic Cell Subsets in Human Vagina to Elicit Local ImmunityRC1AI087379 · NIAID · BAYLOR RESEARCH INSTITUTE · PI OH, SANGKON · 2010 to 2010
$500k
CCR NIH HHS 1RC2A148460-01NCI NIH HHS RC2 CA148460NIAID NIH HHS 1RC1AI087379-01NIAID NIH HHS RC1 AI087379NIAID NIH HHS U19 AI057234
6 · The paper itself

Abstract

Dendritic cells (DCs) are major antigen presenting cells (APCs) that can initiate and control host immune responses toward either immunity or tolerance. These features of DCs, as immune orchestrators, are well characterized by their tissue localizations as well as by their subset-dependent functional specialties and plasticity. Thus, the level of protective immunity to invading microbial pathogens can be dependent on the subsets of DCs taking up microbial antigens and their functional plasticity in response to microbial products, host cellular components and the cytokine milieu in the microenvironment. Vaccines are the most efficient and cost-effective preventive medicine against infectious diseases. However, major challenges still remain for the diseases caused by sexually-transmitted pathogens, including HIV, HPV, HSV and Chlamydia. We surmise that the establishment of protective immunity in the female genital mucosa, the major entry and transfer site of these pathogens, will bring significant benefit for the protection against sexually-transmitted diseases. Recent progresses made in DC biology suggest that vaccines designed to target proper DC subsets may permit us to establish protective immunity in the female genital mucosa against sexually-transmitted pathogens.

Indexed as

Immunity, MucosalBacterial VaccinesDendritic CellsDrug DiscoveryFemaleGenitalia, FemaleHumansSexually Transmitted DiseasesViral VaccinesBacterial VaccinesViral Vaccines

Identifiers

PMID23201532
PMCPMC3596496
OpenAlexW1992816345

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.